Results 11 to 20 of about 1,973 (178)

Sevelamer-associated ischemic colitis with perforation

Gastroenterology Insights, 2015
We present a case of an 83-year-old woman with end-stage renal disease and hyperphosphatemia treated with sevelamer carbonate, who underwent subtotal colectomy for diffuse bowel necrosis and two perforations in the transverse colon.
Rachel Hudacko, Peter Kaye
doaj   +2 more sources

Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis. [PDF]

Hemodial Int
Abstract Introduction Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease‐mineral and bone disorder has been linked to reduced lifespan and worsened quality of life.
Georgopoulos C, Duni A, Stamellou E, Kitsos A, Gouva C, Dounousi E.   +5 more
europepmc   +2 more sources

Colitis Associated With Sevelamer Carbonate: A Case Report

Annals of Internal Medicine: Clinical Cases, 2023
Sevelamer carbonate is an anion-exchange, nonabsorbable resin that is commonly used to treat hyperphosphatemia in patients with advanced chronic kidney disease and end-stage renal disease.
Prajwol Pant, David LaBel, Nora Hernandez Garcilazo, Shailendra Sharma, Sumughda Rayamajhi   +4 more
doaj   +2 more sources

The effects of sevelamer carbonate on blood glucose and inflammatory factors in patients with diabetic kidney disease; a controlled clinical trial [PDF]

Journal of Nephropharmacology, 2021
Introduction: Diabetic nephropathy (diabetic kidney disease) is a complication of diabetes that begins and progresses with several factors, including hyperglycemia, inflammation and oxidative stress.
Shadi Botshekan, Leila Mahmoodnia, Ali Momeni, Tina Jafari, Ali Hasanpour Dehkordi, Mohammadsaleh Ghafari Goosheh   +5 more
doaj   +2 more sources

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial

BMC Nephrology, 2012
Background Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that is secreted from bone and serum level increases as renal function declines.
Bleskestad Inger H, Bergrem Harald, Hartmann Anders, Godang Kristin, Gøransson Lasse G   +4 more
doaj   +2 more sources

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial

Toxins, 2021
P-cresyl sulfate and indoxyl sulfate are strongly associated with cardiovascular events and all-cause mortality in chronic kidney disease (CKD). This randomized controlled trial was conducted to compare the effects between sevelamer and calcium carbonate
Kullaya Takkavatakarn, Pongpratch Puapatanakul, Jeerath Phannajit, Warumphon Sukkumme, Pajaree Chariyavilaskul, Patita Sitticharoenchai, Asada Leelahavanichkul, Pisut Katavetin, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Paweena Susantitaphong   +10 more
doaj   +2 more sources

Whitish Deposits in the Stomach and Duodenum. [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 13, Issue 10, Page 1913-1915, December 2025.
Yang KY, Zhou XJ, Xie W.
europepmc   +2 more sources

Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients [PDF]

Journal of the American Society of Nephrology, 2008
Disturbances in mineral metabolism play a central role in the development of renal bone disease. In a 54-wk, randomized, open-label study, 119 hemodialysis patients were enrolled to compare the effects of sevelamer hydrochloride and calcium carbonate on bone.
Ferreira, A, Frazão, JM, Monier-Faugere, MC, Gil, C, Galvão, J, Oliveira, C, Baldaia, J, Rodrigues, I, Santos, C, Ribeiro, S, Hoenger, R, Duggal, A, Malluche, HH   +12 more
openaire   +4 more sources

Case report: Sevelamer-associated colitis—a cause of pseudotumor formation with colon perforation and life-threatening bleeding [PDF]

Frontiers in Medicine, 2023
Chronic kidney disease (CKD) is a very common chronic non-communicable disease. Phosphate and calcium metabolism disorders are one of the most common features of CKD.
Margareta Fistrek Prlic, Mislav Jelakovic, Marko Brinar, Marko Brinar, Dora Grgic, Ivan Romic, Zlatko Marusic, Ema Ivandic, Bojan Jelakovic, Bojan Jelakovic, Ivana Vukovic Brinar, Ivana Vukovic Brinar, Zeljko Krznaric, Zeljko Krznaric   +13 more
doaj   +2 more sources

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Toxins, 2019
High serum levels of gut-derived uremic toxins, especially p-cresyl sulfate (pCS), indoxyl sulfate (IS) and indole acetic acid (IAA), have been linked to adverse outcomes in patients with chronic kidney disease (CKD).
Youssef Bennis, Yan Cluet, Dimitri Titeca-Beauport, Najeh El Esper, Pablo Ureña, Sandra Bodeau, Christian Combe, Bertrand Dussol, Denis Fouque, Gabriel Choukroun, Sophie Liabeuf   +10 more
doaj   +2 more sources